Ovarian Cancer Vaccine Clinical Trial Begins at Cancer Treatment Centers of America 11/13/2009
More...
|
AEterna Zentaris (AEZS) Announces Positive Preliminary Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Ovarian Cancer 11/2/2009
More...
|
Nektar Therapeutics (NKTR) Completes Enrollment Ahead of Schedule in Phase 2 Clinical Trial Evaluating NKTR-102 in Patients with Platinum-Resistant Ovarian Cancer 10/28/2009
More...
|
Endocyte, Inc. Presents Data on EC145 in Treatment of Ovarian Cancer Before the European Society of Gynecological Oncology 10/21/2009
More...
|
EU Agency Backs Zeltia Group (18494051.MA) Drug for Ovarian Cancer 9/25/2009
More...
|
Nektar Therapeutics (NKTR): NKTR-102 Shows Encouraging Anti-Tumor Activity in Ovarian Cancer in Phase 1 and Preclinical Data Presented at the ECCO 15 and 34th ESMO Multidisciplinary Congress 9/22/2009
More...
|
FDA Issues Complete Response Letter For Centocor Ortho Biotech Products, L.P.'s Trabectedin Combined With DOXIL; Agency Requests Additional Information 9/11/2009
More...
|
Antibody Linked To Chemotherapy Drug Inhibits Ovarian Cancer In Lab, University of Texas MD Anderson Cancer Center Study 8/10/2009
More...
|
Antibody Linked To Chemotherapy Drug Inhibits Ovarian Cancer, University of Texas MD Anderson Cancer Center Study 7/30/2009
More...
|
CytRx Corporation (CYTR) Drug Candidate INNO-206 Results in Ovarian Tumor Shrinkage in Animal Trials 7/28/2009
More...
|
Abbott Laboratories (ABT)' (JOBS) New Diagnostic Biomarker Test Shows Promise in Monitoring Ovarian Cancer 7/22/2009
More...
|
U.S. Panel Votes to Reject Johnson & Johnson (JNJ), Zeltia Group (18494051.MA) Cancer Drug, Yondelis 7/17/2009
More...
|
Hormone Therapy Boosts Risk for Ovarian Cancer in University of Copenhagen Study 7/15/2009
More...
|
US FDA Staff Question Johnson & Johnson (JNJ), Zeltia Group (18494051.MA) Cancer Drug Data 7/13/2009
More...
|
Zeltia Group (18494051.MA)'s Yondelis Gets First OK for Ovarian Cancer in the Philippines; U.S. FDA Panel to Review Drug July 15 7/10/2009
More...
|
Regeneron Pharmaceuticals, Inc. (REGN), Sanofi-Aventis (France) (SASY.PA) to Not Submit Ovarian Cancer Drug Data 6/12/2009
More...
|
Earlier Treatment Fails to Improve Survival in Ovarian Cancer, Mount Vernon Cancer Centre Study 6/2/2009
More...
|
Access Pharmaceuticals (ACCP) Provides Update on ProLindac(TM) Phase 2 Ovarian Cancer Trial and Clinical Development Plan 6/1/2009
More...
|
Sunesis Pharmaceuticals, Inc. (SNSS) Announces New Data on Voreloxin for Acute Myeloid Leukemia and Ovarian Cancer Will Be Presented at American Society of Clinical Oncology 5/26/2009
More...
|
Plant-Based Flavonoid May Cut Ovarian Cancer Risk, Brigham and Women's Hospital And Harvard Medical School Study 4/23/2009
More...
|
Plant-Based Flavonoid May Cut Ovarian Cancer Risk 4/23/2009
More...
|
First Candidate from Esperance Pharmaceuticals's Targeted Anti-cancer Platform, EP-100, Establishes Preclinical Proof of Concept 4/22/2009
More...
|
Oasmia Says FDA Grants Paclical(r) Orphan Drug Designation for Ovarian Cancer in the US 4/14/2009
More...
|
Myriad Genetics, Inc. (MYGN) Applauds New American College of Obstetricians and Gynecologist Guidelines for Hereditary Breast and Ovarian Cancer 3/25/2009
More...
|
Morphotek Inc. and Eisai Corporation of North America Announce FDA Special Protocol Assessment (SPA) for Phase III Trial Evaluating Farletuzumab in Relapsed Ovarian Cancer 3/23/2009
More...
|
Access Pharmaceuticals (ACCP) Announces Positive ProLindac(TM) Phase 2 Ovarian Cancer Clinical Trial Results 3/5/2009
More...
|
Endocyte, Inc. Begins Phase II Clinical Trial of EC145 For Treatment of Women with Ovarian Cancer 2/19/2009
More...
|
Infinity Pharmaceuticals, Inc. Announces Hedgehog Pathway Preclinical Data in Ovarian Cancer 2/9/2009
More...
|
IVF Drugs Cancer Risk 'Ruled Out', Danish Cancer Society Study 2/6/2009
More...
|
Angiogenesis Linked To Poor Survival In Patients With Rare Type Of Ovarian Cancer, University of Texas MD Anderson Cancer Center Study 2/5/2009
More...
|
Ovarian Surgery Doesn't End All Cancer Risk, University of Pennsylvania Study 1/14/2009
More...
|
USA FDA Allows BioCancell Therapeutics to Commence Phase I/IIa Ovarian and Pancreatic Clinical Trials 1/14/2009
More...
|
Northwest Biotherapeutics (NWBT) Reports Encouraging Data on First Patients Who Have Completed Its Phase I/II Clinical Trial of DCVax(R)-L in Metastatic Ovarian Cancer 12/29/2008
More...
|
Ovarian Cancer Survival Linked To Two Key Proteins, University of Texas MD Anderson Cancer Center Study 12/18/2008
More...
|
Possible Way To Treat Ovarian Cancer Reported By University of California, Berkeley (CAL) Researchers 12/16/2008
More...
|
Curis, Inc. (CRIS) Announces Genentech, Inc. (DNA)’s Initiation of Phase II Clinical Trial in Advanced Ovarian Cancer with Hedgehog Pathway Inhibitor 12/8/2008
More...
|
HealthLinx Release: New Diagnostic 98% Accurate Detecting Early Stage Ovarian Cancers 12/8/2008
More...
|
Morphotek Inc. Announces Initiation of Farletuzumab Phase II Study In Platinum-Resistant Ovarian Cancer 12/2/2008
More...
|
New Platinum-phosphate Compounds Kill Ovarian Cancer Cells, Other Cancer Cells, Ohio State University Study 11/20/2008
More...
|
Protein Compels Ovarian Cancer Cells To Cannibalize Themselves, University of Texas MD Anderson Cancer Center Study 11/17/2008
More...
|
Independent Data Monitoring Committee Recommends Marshall Edwards, Inc. (NVGN)'s OVATURE Trial Continue 11/13/2008
More...
|
Independent Data Monitoring Committee Recommends Marshall Edwards, Inc. (NVGN)'s OVATURE Trial Continue 11/12/2008
More...
|
World First Early Stage Diagnostic Test For Ovarian Cancer, Developed by HealthLinx Scientists 10/29/2008
More...
|
Laboratory Corporation of America Holdings (LH) Stops Sales of Ovarian Cancer Test 10/27/2008
More...
|
Exiqon A/S Announces Positive Clinical Data From EORTC Clinical Trial Showing Oncotech EDR Assay Predicts Resistance to Platinum-Based Therapy in Ovarian Cancer 10/27/2008
More...
|
Exiqon A/S Announces Positive Clinical Data From EORTC Clinical Trial Showing Oncotech EDR Assay Predicts Resistance to Platinum-Based Therapy in Ovarian Cancer 10/27/2008
More...
|
Sunesis Pharmaceuticals, Inc. (SNSS) Announces Updated Clinical Data of Voreloxin in Platinum-Resistant Ovarian Cancer 10/27/2008
More...
|
OXiGENE (OXGN) Reports Positive Phase 2 Interim Results in Platinum-Resistant Ovarian Cancer for Lead Vascular Disrupting Agent, ZYBRESTAT(tm) 10/27/2008
More...
|
Why Past Oral Contraceptive Use Dramatically Lowers Risk Of Ovarian And Uterine Cancers, Wake Forest University School of Medicine Study 10/22/2008
More...
|
Laboratory Corporation of America Holdings (LH) Ovarian Cancer Test Sales Are Illegal, FDA Warns 10/9/2008
More...
|
AEterna Zentaris (AEZS) Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 10/2/2008
More...
|
Vascular Marker Of Ovarian Cancer Identified By University of Pennsylvania Scientists 9/29/2008
More...
|
Researchers ID Ovarian Cancer Biomarker, University of Pennsylvania Ovarian Cancer Study 9/24/2008
More...
|
India's Sun Pharmaceutical Industries Ltd Gets US Nod to Sell Cancer Drug 9/23/2008
More...
|
Zeltia Group (18494051.MA) Drug Delays Progression of Ovarian Cancer 9/15/2008
More...
|
GlaxoSmithKline (GSK)'s Pazopanib Shows Promise in Ovarian Cancer 9/15/2008
More...
|
Curis, Inc. (CRIS) Announces GDC-0449 Phase II Ovarian Cancer Trial Design 8/28/2008
More...
|
Spain's Zeltia SA Jumps on Ovarian Cancer Drug News 8/7/2008
More...
|
Enrollment of Breast and Ovarian Cancer Patients Commenced for Combination Therapy Trial to Include Generex Biotechnology Corporation (GNBT)'s Novel Immunotherapeutic Vaccine 8/7/2008
More...
|
New Computer Assisted Diagnostic Tests for Ovarian Cancer, Cervical Cancer and Endometrial Cancer to Be Jointly Developed by Health Discovery Corporation (DWCM.OB) and DCL Medical Laboratories 7/24/2008
More...
|
Analgesic Drugs Don't Reduce Ovarian Cancer Risk, Fred Hutchinson Cancer Research Center Study Finds 7/18/2008
More...
|
Abeome Corporation and Cato Research to Collaborate on Ovarian Cancer Therapeutic 7/15/2008
More...
|
Ovarian Cancer's Specific Scent Detected By Dogs in University Hospital Led Study 6/26/2008
More...
|
Vermillion Files 510(k) Application With FDA for OVA1 Ovarian Tumor Triage Test 6/25/2008
More...
|
Laboratory Corporation of America Holdings (LH) Announces Availability of OvaSureTM 6/24/2008
More...
|
Symptoms Plus Blood Test Boost Ovarian Cancer Detection, Fred Hutchinson Cancer Research Center Researchers Find 6/23/2008
More...
|
Oncolytics Biotech Inc. (ONC.TO) Announces Start of Enrolment in Phase 1/2 Ovarian Cancer Clinical Trial with REOLYSIN(R) 6/10/2008
More...
|
Novelos Therapeutics, Inc. Announces Presentation of Encouraging Results in Phase 2 Ovarian Cancer Trial at 2008 American Society of Clinical Oncology Meeting by MGH and Novelos Therapeutics, Inc./Harvard Cancer Centers 6/2/2008
More...
|
Nektar Therapeutics (NKTR) Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan) 6/2/2008
More...
|
Sunesis Pharmaceuticals, Inc. (SNSS) Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th American Society of Clinical Oncology Annual Meeting 6/2/2008
More...
|
Bayer HealthCare Pharmaceuticals (BAY) and Onyx Pharmaceuticals, Inc. (ONXX) Release: New Nexavar Data Presented in Multiple Tumor Types at 44th American Society of Clinical Oncology Annual Meeting 6/2/2008
More...
|
Poniard Pharmaceuticals, Inc. (PARD) Announces Positive Efficacy and Safety Data From Phase 1 Trial of Picoplatin in Multiple Tumor Types Including Ovarian Cancer - Poster Presented at American Society of Clinical Oncology Annual Meeting 6/2/2008
More...
|
Access Pharmaceuticals (ACCP) Presents Favorable Ovarian Cancer Data and Clinical Update on ProLindac(TM) Development 5/28/2008
More...
|
Sanofi-Aventis (France) (SASY.PA) and Regeneron Pharmaceuticals, Inc. (REGN) Cancer Drug Misses Study Goal 5/21/2008
More...
|
Marshall Edwards, Inc. (NVGN) Release: Extended Accrual Time and Decreased Sample Size for OVATURE, a Multinational Phase III Clinical Study for Women With Recurrent Ovarian Cancer 5/9/2008
More...
|
BiPar Sciences, Inc. Expands Phase 2 Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer 5/8/2008
More...
|
Ovarian Cancer Stem Cells Identified, Characterized by Yale University School Of Medicine Researchers 4/18/2008
More...
|
FASgen, Inc. Presents Ovarian Cancer Efficacy and Toxicology Data 4/18/2008
More...
|
Insert Therapeutics Inc. to Initiate a Multinational Phase II Clinical Trial of Lead Drug Candidate IT-101 in Ovarian Cancer 4/17/2008
More...
|
BiPar Sciences, Inc.'s BSI-201 Demonstrates Significant Tumor Growth Inhibition and Increased Survival Rates in Preclinical Ovarian Cancer Studies 4/14/2008
More...
|
AVAX Technologies, Inc. (AVXT) Announces Initiation of Clinical Study with Autologous Ovarian Cancer Vaccine (OVax(R)) 4/9/2008
More...
|
Oxea Presents Its First New Product 4/9/2008
More...
|
Novelos Therapeutics, Inc. Announces Continued Encouraging Results in Ongoing Phase 2 Ovarian Cancer Trial at Dana-Farber Cancer Institute/Harvard Cancer Center 3/31/2008
More...
|
Novogen Limited (NVGN) Compound NV-128 Uses mTOR Pathway to Induce Cell Death in Chemo-Resistant Ovarian Cancer Cells 3/25/2008
More...
|
Vermillion Announces Positive Results From Clinical Trial of Ovarian Tumor Triage Test; Study Meets Primary Endpoints 3/20/2008
More...
|
Drug To Prevent Spread Of Ovarian Cancer, University of Chicago Study 3/18/2008
More...
|
Advanced-Stage Ovarian Cancer Patients With BRCA Live Longer, May Respond Better To Treatment, University of Texas M. D. Anderson Cancer Center Study Shows 3/12/2008
More...
|
Recurrent Low-Grade Carcinoma Of The Ovary Less Responsive To Chemo Than More Common Ovarian Cancers, University of Texas Study 3/11/2008
More...
|
Ovature Release: Phenoxodiol Trials Highlighted at Ovarian Cancer Action International Conference 3/10/2008
More...
|
Sunesis Pharmaceuticals, Inc. (SNSS) Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer 3/10/2008
More...
|
Vermillion's Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease 3/10/2008
More...
|
Fujirebio Diagnostics, Inc. Release: New Ovarian Cancer Test Now Available in Europe 3/4/2008
More...
|
M. D. Anderson Cancer Center Researchers Identify And Shut Down Protein That Fuels Ovarian Cancer 2/27/2008
More...
|
Laboratory Corporation of America Holdings (LH) Release: Phase II Results For Yale University's Early Stage Ovarian Cancer Blood Test 99% Accurate 2/21/2008
More...
|
HealthLinx Announces Accuracy of Early Stage Ovarian Cancer Diagnostic Confirmed 2/21/2008
More...
|
Blood Test Detects Ovarian Cancer Early 2/18/2008
More...
|
New Test Detects Early Stage Ovarian Cancer With 99 Percent Accuracy 2/13/2008
More...
|
AEterna Zentaris (AEZS) Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers 2/12/2008
More...
|
Study Reveals Why Certain Ovarian Cancers Develop Resistance To Platinum-Based Chemotherapy 2/11/2008
More...
|
BioNumerik Pharmaceuticals, Inc. Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R) 2/7/2008
More...
|
Calibrant Biosystems Announces Ovarian and Breast Cancer Drug Discovery Partnership with Yale University 2/7/2008
More...
|
Birth Control Pill Lowers Ovarian Cancer Risk, Oxford University Study 1/25/2008
More...
|
Coffee Linked To Lower Ovarian Cancer Risk 1/22/2008
More...
|
VioQuest Pharmaceuticals, Inc. (VQPH.OB) Release: Novel Akt Inhibitor VQD-002 Shown to Reverse Cisplatin Resistance in Ovarian Cancer 1/22/2008
More...
|
Threshold Pharmaceuticals, Inc. (THLD) Updates Glufosfamide Clinical Development Program, Stops Ovarian Cancer Trial 1/18/2008
More...
|
Ashkenazi Ovarian Cancer Patients with BRCA Mutations Live Longer Than Those with Normal Gene 1/2/2008
More...
|
OXiGENE (OXGN) Reports Positive Results in Phase 2 Study of ZYBRESTAT(TM) in Platinum-Resistant Ovarian Cancer 12/31/2007
More...
|
Northwest Biotherapeutics (NWBT) Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L at University of Pennsylvania First Patients Enrolled and Being Treated 12/27/2007
More...
|
Fujirebio Diagnostics, Inc.: Researchers Identify Indicator of Ovarian Cancer 12/18/2007
More...
|
Fujirebio Diagnostics, Inc.: Researchers Identify Indicator of Ovarian Cancer 12/17/2007
More...
|
Extracellular Protein Sensitizes Ovarian Cancer Cells to Chemotherapy 12/11/2007
More...
|
United Therapeutics Corporation (UTHR) Release: Clinical Studies of OvaRex in Advanced Ovarian Cancer Fail to Meet Primary Endpoint 12/5/2007
More...
|
GeoPharma, Inc. (GORX) Acquires Rights for an Early Stage Diagnostic Urine Test for Ovarian Cancer 12/3/2007
More...
|
Mass Screening Ovarian Cancer Diagnostic Would Boost Survival Rates, UK 11/27/2007
More...
|
National Cancer Institute Researchers Uncover Unusual Association Between Cell Survival Proteins and Ovarian Cancer Aggressiveness 11/16/2007
More...
|
HealthLinx's Cancer Test on Market Soon 11/16/2007
More...
|
Ultrasound May Better Classify Ovarian Tumors 11/14/2007
More...
|
Immunologic Death Blow to Cancer Cells, Howard Hughes Medical Institute Study 11/13/2007
More...
|
Research Highlights Important Indicators of Early-stage Ovarian Cancer 11/12/2007
More...
|
Monarch LifeSciences LLC Proteomic Technologies Identify and Quantified Promising Biomarkers in Ovarian Cancer Cells 11/7/2007
More...
|
Novel Medication Improves Ovarian Cancer Treatment 11/1/2007
More...
|
Vermillion Protein Biomarkers Help Detect Early-Stage Ovarian Cancer and Predict Survival 10/31/2007
More...
|
Fujirebio Diagnostics, Inc. Issued Patent for Ovarian Cancer Biomarker 10/31/2007
More...
|
Marshall Edwards, Inc. (NVGN) Release: European Symposium Focuses on Phenoxodiol as an Investigational Drug for Ovarian Cancer Management 10/29/2007
More...
|
Vermillion to Present Multiple Studies on Ovarian Cancer Diagnostics Program at European Society of Gynecological Oncology Meeting 10/25/2007
More...
|
Mayo Clinic Reports Possible New Therapy for Patients with Platinum-Resistant Ovarian Cancer 10/24/2007
More...
|
Sunesis Pharmaceuticals, Inc. (SNSS) Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference 10/24/2007
More...
|
EntreMed, Inc. (ENMD) Presents Results for Panzem(R) NCD Phase 2 Ovarian Cancer Study Results Demonstrate Activity in Advanced Disease 10/24/2007
More...
|
Vermillion Completes Clinical Trial Enrollment for Ovarian Cancer Triage Test 10/24/2007
More...
|
Ovature Release: European Symposium on Phenoxodiol as an Investigational Drug for Ovarian Cancer Management 10/23/2007
More...
|
Sunesis Pharmaceuticals, Inc. (SNSS) Hosts Conference Call to Discuss Preliminary SNS-595 Activity in its Ovarian Cancer Clinical Trial 10/23/2007
More...
|
Introgen Therapeutics, Inc. (INGN) Announces Publication of Research Showing Promising Activity of INGN 241 Combined with Velcade® in Ovarian Cancer 10/2/2007
More...
|
Mutation of the COX2 Gene Can Double or Treble a Woman's Risk of Ovarian Cancer 9/26/2007
More...
|
BioCurex Inc. (BOCX) Presents RECAF Point-of-Care Test Results At International Cancer Congress 9/18/2007
More...
|
Myriad Genetics, Inc. (MYGN) Launches Awareness Advertising Campaign to Educate Women About Hereditary Risks of Breast and Ovarian Cancers 9/10/2007
More...
|
Ovarian Cancer: The Not-So-Silent Killer 9/6/2007
More...
|
Marshall Edwards, Inc. (NVGN) Release: A Worldwide Phase III Clinical Trial Seeks U.S. Patients to Explore Investigational Drug Phenoxodiol 8/30/2007
More...
|
Marshall Edwards, Inc. (NVGN) Release: First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial 8/27/2007
More...
|
Novogen Limited (NVGN) Release: First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial 8/27/2007
More...
|
Access Pharmaceuticals (ACCP) Provides Update on Clinical Development Plan of ProLindac; Additional Clinical Trial Plans for 4Q07/1Q08 8/20/2007
More...
|
Aethlon Medical (AEMD) Submits Ovarian Cancer Treatment Grant 8/7/2007
More...
|
Testicular Protein Vaccine May Fight Ovarian Cancer 7/24/2007
More...
|
Expression Genetics, Inc. Announces Further Clinical Advancement of its Gene-Based IL-12 Therapy Co-administered with Standard Chemotherapy for Treatment of Ovarian Cancer 7/20/2007
More...
|
Antisoma PLC (ASM.L) and Novartis Corporation (NVS) Drug Fails in Ovarian Cancer 7/12/2007
More...
|
Antisoma PLC (ASM.L) Announces Further Data from ASA404 Ovarian Cancer Trial 7/12/2007
More...
|
Goodwin Biotechnology, Inc. and Menarini Group Announce the Successful Completion of Their Strategic US-Italian Cooperation to Fight Ovarian Cancer 7/10/2007
More...
|
Eli Lilly and Company (LLY) and Translational Genomics Research Institute (TGen) Researchers Identify Genetic Mutation That May Alter Patients' Response to Cancer Therapeutics 7/5/2007
More...
|
AstraZeneca PLC (AZN) and Myriad Genetics, Inc. (MYGN) Release: Patients Begin Enrolling in Studies to Determine if Women With BRCA 1 & 2 Positive Cancer may Receive Greater Benefit From New Treatment 6/19/2007
More...
|
Novelos Therapeutics, Inc. Announces Encouraging Results in Ongoing Phase 2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care 6/18/2007
More...
|
Hormone Therapy Offers New Hope for Ovarian Cancer Patients 6/15/2007
More...
|
NeoClone Gets $750,000 Grant 6/6/2007
More...
|
Telik, Inc. (TELK) (Jobs) Announces Clinical Hold on TELCYTA Trials 6/5/2007
More...
|
GlaxoSmithKline (GSK)'s (Jobs) Shows Positive Results from Ongoing Phase II Studies of Pazopanib 6/5/2007
More...
|
Abraxis BioScience, Inc. Release: New Data Shows Promising Antitumor Activity with nab-paclitaxel (ABRAXANE(R)) in Combination and as a Single Agent for the Treatment of Lung and Ovarian Cancers 6/5/2007
More...
|
KOSAN Biosciences, Inc. (KOSN) Presents Promising Phase 1 Data on Second-Generation Hsp90 Inhibitor, Alvespimycin, Showing Antitumor Activity in Refractory Breast and Ovarian Cancers at American Society of Clinical Oncology 6/4/2007
More...
|
Marshall Edwards, Inc. (NVGN) Release: OVArian TUmor REsponse ('OVATURE') Trial Enrolls First U.S. Patient 6/1/2007
More...
|
Abraxis BioScience, Inc.: New Data Highlighting ABRAXANE as Single Agent and in Combination for the Treatment of Breast, Lung and Ovarian Cancers to Be Presented at American Society of Clinical Oncology 5/30/2007
More...
|
Ultrasound Screening May Catch Ovarian Cancer Early 5/29/2007
More...
|
Expression Genetics, Inc. Receives Orphan Drug Grant from FDA for Clinical Development of EGEN-001 for Treatment of Ovarian Cancer 5/3/2007
More...
|
Researchers Employ ZONARE Medical Systems, Inc. Ultrasound Technology in Study to Detect Early Ovarian Cancer 4/24/2007
More...
|
Two Studies Link Hormones and Cancer in Women 4/19/2007
More...
|
Provista Life Sciences LLC Announces the Opening of Its Clinical Laboratory - Provista Diagnostics (PDx) 4/19/2007
More...
|
Expression Genetics, Inc. Announces Successful Completion of Phase I Trial of Gene-Based IL-12 for Treatment of Ovarian Cancer 4/16/2007
More...
|
Ciphergen Biosystems, Inc. (CIPH) Discovers Protein Biomarkers Useful for Diagnosis of Early-Stage Ovarian Cancer 4/16/2007
More...
|
University of Michigan Health System Study Pries into Ovarian Cancer's Deadly Secrets 4/11/2007
More...
|
RNA Splicing Factor Implicated in Ovarian Tumor Cell Growth, University of Illinois Study Finds 4/10/2007
More...
|
University of British Columbia Discovery May Lead to 'Smart' Therapies for Breast, Ovarian Cancer 3/19/2007
More...
|
Prima Biomed (PRR.AX) Final Phase IIa Results for Ovarian Cancer Treatment Exceeded Expectations 3/14/2007
More...
|
Alethia BioTherapeutics, Inc. Announces Collaborative Agreement With Biosite Incorporated (BSTE) for Antibody Development in Ovarian Cancer 3/12/2007
More...
|
Ovarian Cancer May Mimic Fallopian Tube Formation, Georgia Institute of Technology Study Finds 3/8/2007
More...
|
University of Michigan Health System Researchers Identify Ovarian Cancer Biomarkers 3/7/2007
More...
|
Ciphergen Biosystems, Inc. (CIPH) Presents Data Validating Ovarian Cancer Triage Test at Society of Gynecologic Oncologists Annual Meeting 3/5/2007
More...
|
Ciphergen Biosystems, Inc. (CIPH) Initiates Clinical Trial For Ovarian Cancer Triage Test 2/13/2007
More...
|
Threshold Pharmaceuticals, Inc. (THLD) Initiates Phase 2 Clinical Trial Evaluating Glufosfamide In Patients With Platinum-Resistant Ovarian Cancer 1/30/2007
More...
|
BTG plc (BGC.L)'s Plevitrexed Shows Promising Efficacy And Tolerability In A Phase I/II Study 1/22/2007
More...
|
Genentech, Inc. (DNA) And Roche Holding AG (RHHBF.PK) Drug Trial Fails Main Goal 1/5/2007
More...
|
Oncolytics Biotech Inc. (ONC.TO) Announces Approval For U.K. Clinical Trial Investigating REOLYSIN(R) In Combination With Gemcitabine 1/3/2007
More...
|
Thyroid Cancer Discovery Points To New Treatments, Prevention 12/29/2006
More...
|
Telik, Inc. (TELK) Drug Fails Trials In Lung, Ovarian Cancer 12/26/2006
More...
|
Oncolytics Biotech Inc. (ONC.TO) Announces Approval For U.K. Clinical Trial Investigating REOLYSIN(R) In Combination With Paclitaxel And Carboplatin 12/26/2006
More...
|
Sunesis Pharmaceuticals, Inc. (SNSS) Initiates Phase 2 Clinical Trial Of SNS-595 In Ovarian Cancer 12/21/2006
More...
|
Ciphergen Biosystems, Inc. (CIPH) Chooses Mosaic To Develop Broad Reimbursement Strategy For Ovarian Tumor Triage Test 12/21/2006
More...
|
'Clumping' Protein Linked To Return Of Ovarian Cancer 12/18/2006
More...
|
Ciphergen Biosystems, Inc. (CIPH) Engages PrecisionMed, Inc. As Clinical Trial CRO For Ovarian Tumor Triage Test Clinical Trials 12/15/2006
More...
|
Symptom Sscreening Advances Early Ovarian Cancer Detection 12/11/2006
More...
|
Marshall Edwards, Inc. (NVGN) Release: First Patient Treated In Phase III Ovarian Cancer Trial 11/27/2006
More...
|
New Drug Combo May Lengthen Ovarian Cancer Survival 11/15/2006
More...
|
CuraGen Corporation (CRGN) And TopoTarget A/S Announce Initiation Of NCI-Sponsored Phase II Trial Of PXD101 For Ovarian Cancer 11/14/2006
More...
|
Younger Women Survive Ovarian Cancer Better 11/8/2006
More...
|
EntreMed, Inc. (ENMD) Commences Phase 2 Clinical Trial With Panzem(R) NCD In Ovarian Cancer 11/1/2006
More...
|
Family Cancer Risk "Without Gene" 10/31/2006
More...
|
Antisoma PLC (ASM.L) Presents Positive Tumor Response Data From AS1404 Phase II Trial In Ovarian Cancer 10/16/2006
More...
|
Ciphergen Biosystems, Inc. (CIPH) Presents Data At IGCS Supporting Use of Protein Biomarkers To Discriminate Malignant From Benign Pelvic Disease 10/16/2006
More...
|
Antisoma PLC (ASM.L)'s Preliminary Results For The Year Ended 30 June 2006 10/16/2006
More...
|
Hormone Therapy Linked To Ovarian Cancer Risk 10/10/2006
More...
|
PharmaMar S.A. Release: Successful Planned Independent Analysis Of Pivotal Phase III Trial Of YONDELIS® In Ovarian Cancer 10/5/2006
More...
|
Prima Biomed (PRR.AX) Prepares For Next CVac (TM) Ovarian Cancer Clinical Trial With Cell Manufacturing Scale-Up 10/3/2006
More...
|
Early Results Indicate Radiofreqency Ablation Useful In Treating Ovarian Cancer Metastasis 9/29/2006
More...
|
Dendritic Nanotechnologies Limited Receives National Cancer Institute Contract To Develop Dendrimer-Based Diagnostic And Therapeutic Delivery System For Ovarian Cancer 9/29/2006
More...
|
Peter MacCallum Cancer Centre And Affymetrix (Santa Clara, California) (AFFX) Initiate Five-Year Translational Research Collaboration 9/27/2006
More...
|